期刊
FLUID PHASE EQUILIBRIA
卷 357, 期 -, 页码 43-49出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.fluid.2013.05.025
关键词
Solubility; Poorly water-soluble pharmaceutical; Co-solvent; Cyclodextrin
The purpose of this study is to measure the solubilities of poorly water-soluble drugs, and to enhance their solubilities by adding co-solvents. Etodolac, a cyclooxygenase-2 (cox-2) inhibitor in non-steroid anti-inflammatory drugs (NSAIDs), was selected as a model pharmaceutical compound. The solubilities of etodolac were determined at 298.15K in mixtures of water and the following six cyclodextrins (CDs) using high-performance liquid chromatography: alpha-CD, beta-CD, gamma-CD, 2-hydroxypropyl-beta-CD, 2-hydroxyethyl-beta-CD, and methyl-beta-CD. With the exception of gamma-CD, the experimental solubility data were correlated using a modified Chrastil model. Additionally, the solubilization power of each correlated co-solvent-solute system was evaluated using a log-linear model. Finally, the stability constants were determined using the Takeru Higuchi-Connors solubility method. (C) 2013 Elsevier B.V. All rights reserved,
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据